Compare VFF & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VFF | DERM |
|---|---|---|
| Founded | 1989 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.2M | 190.3M |
| IPO Year | 2013 | 2021 |
| Metric | VFF | DERM |
|---|---|---|
| Price | $1.99 | $6.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | N/A | ★ $12.67 |
| AVG Volume (30 Days) | ★ 702.8K | 149.4K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 184.38 | 34.72 |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $215,937,000.00 | $61,858,000.00 |
| Revenue This Year | $12.19 | $39.72 |
| Revenue Next Year | $15.82 | $63.24 |
| P/E Ratio | $98.25 | ★ N/A |
| Revenue Growth | N/A | ★ 10.20 |
| 52 Week Low | $1.38 | $4.31 |
| 52 Week High | $4.99 | $9.56 |
| Indicator | VFF | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 45.19 | 40.16 |
| Support Level | $1.90 | $5.80 |
| Resistance Level | $2.11 | $6.59 |
| Average True Range (ATR) | 0.08 | 0.37 |
| MACD | 0.02 | -0.14 |
| Stochastic Oscillator | 30.99 | 10.34 |
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.